Login / Signup

Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature.

Maziar EmamikhahMansoureh BabadiMehrnoush MehrabaniMehdi JaliliMaryam PouranianPeyman DaraieFahimeh MohagheghSharmin AghavaliMaryam ZaribafianMohammad Rohani
Published in: Journal of neurovirology (2021)
Opsoclonus-myoclonus-ataxia syndrome is a heterogeneous constellation of symptoms ranging from full combination of these three neurological findings to varying degrees of isolated individual sign. Since the emergence of coronavirus disease 2019 (COVID-19), neurological symptoms, syndromes, and complications associated with this multi-organ viral infection have been reported and the various aspects of neurological involvement are increasingly uncovered. As a neuro-inflammatory disorder, one would expect to observe opsoclonus-myoclonus syndrome after a prevalent viral infection in a pandemic scale, as it has been the case for many other neuro-inflammatory syndromes. We report seven cases of opsoclonus-myoclonus syndrome presumably parainfectious in nature and discuss their phenomenology, their possible pathophysiological relationship to COVID-19, and diagnostic and treatment strategy in each case. Finally, we review the relevant data in the literature regarding the opsoclonus-myoclonus syndrome and possible similar cases associated with COVID-19 and its diagnostic importance for clinicians in various fields of medicine encountering COVID-19 patients and its complications.
Keyphrases
  • coronavirus disease
  • sars cov
  • respiratory syndrome coronavirus
  • oxidative stress
  • systematic review
  • risk factors
  • palliative care
  • depressive symptoms
  • cerebral ischemia